DTPA Renal Scan: Indications and Protocol
When to Order
Tc-99m DTPA renal scans should be ordered for evaluating severe grade 3 and 4 hydronephrosis in infants (delayed until at least 2 months of age due to low neonatal glomerular filtration rate), but Tc-99m MAG3 is strongly preferred over DTPA when obstruction or impaired renal function is suspected. 1
Primary Indications
In pediatric hydronephrosis:
- Severe grade 3 or 4 hydronephrosis evaluation, typically performed in concert with VCUG 1
- Assessment of split renal function and renal washout curves 1
- Critical timing consideration: Examinations must be delayed until at least 2 months of age due to lower glomerular filtration rate in newborns 1
In adult patients:
- Renal visualization and assessment of renal perfusion 2
- Estimation of glomerular filtration rate 2
- Brain imaging (intravenous administration) 2
- Renal transplant dysfunction evaluation (though not routinely recommended as baseline per European Association of Urology guidelines) 3
Important Limitation
DTPA has significant disadvantages compared to MAG3: Its extraction fraction is only approximately 20%, resulting in greater background activity versus renal activity, making it inferior for evaluating obstruction or impaired renal function 1. DTPA is excreted primarily by glomerular filtration and is not excreted by tubules, limiting its utility in obstruction evaluation 3.
Proper Protocol
Dosing for Renal Scintigraphy
Adults:
- Renal visualization and perfusion assessment: 370-740 MBq (10-20 mCi) intravenous 2
- Renal visualization with GFR estimation: 111-185 MBq (3-5 mCi) intravenous 2
- GFR estimation only (no imaging): 7.4-18.5 MBq (0.2-0.5 mCi) intravenous 2
Pediatric patients:
- Renal visualization and perfusion: 3.7-7.4 MBq/kg (0.1-0.2 mCi/kg) intravenous 2
- Minimum dose: 37 MBq (1 mCi) 2
- Maximum dose: 185 MBq (5 mCi) 2
- GFR estimation only: 7.4-18.5 MBq (0.2-0.5 mCi) 2
Image Acquisition
For renal visualization and perfusion assessment:
For GFR estimation with imaging:
For GFR estimation without imaging:
- Blood sampling only is performed 2
Safety Considerations
- Use waterproof gloves and effective shielding, including syringe shields, during preparation and handling 2
- Do not administer more than one dose 2
Clinical Decision Algorithm
When evaluating pediatric hydronephrosis:
If patient is <2 months old: Delay nuclear medicine imaging due to immature glomerular filtration 1
If patient is ≥2 months old with severe (grade 3-4) hydronephrosis:
Interpretation for surgical decision-making:
For renal transplant evaluation:
- DTPA can monitor perfusion (blood flow) and uptake (glomerular filtration rate) 3
- DTPA perfusion patterns are more sensitive than MAG3 in diagnosing transplant dysfunction 3
- However, routine baseline dynamic renal scintigraphy is not recommended per current EAU guidelines 3
Common Pitfalls
- Using DTPA instead of MAG3 in obstruction: DTPA's primary glomerular filtration mechanism and lack of tubular excretion makes it inferior for obstruction evaluation, as it only demonstrates early impact on glomerular filtration 3
- Imaging too early in neonates: The lower glomerular filtration rate in newborns necessitates waiting until at least 2 months of age 1
- Misinterpreting background activity: DTPA's lower extraction fraction (20%) creates more background noise compared to MAG3 (40-50% extraction fraction), potentially obscuring renal detail 1